Compounded tirzepatide: Where It Stands in 2026
Compounded tirzepatide is Tirzepatide made by a compounding pharmacy rather than the approved brand-name pen. Where it stands with the FDA in 2026, and what to check.
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
At a glance
- Tirzepatide (brand-name drug)
- FDA approved (Mounjaro, Zepbound)
- Compounded version
- Not FDA approved
- Compounded drugs are not reviewed by the FDA for safety or effectiveness.
- Searches per month
- 44,500
Rules
What changed in 2026
- FDA warning letters to five research-peptide sellersEnforcement
- FDA proposes excluding semaglutide, tirzepatide and liraglutide from the 503B bulks listFDA
- Seven FDA warning letters to online sellers of GLP-1 productsEnforcement
Compounding rules for Tirzepatide are changing. Check the tracker for the latest dated entry before relying on any status shown here.
Telehealth
Telehealth brands people search with Tirzepatide
Based on search data only: it shows what people look for, not which brands currently prescribe compounded versions.
| Brand | Price / month | Peptides offered | States | Link |
|---|---|---|---|---|
| Ro | Not stated | Not stated | Not stated | — |
| Hers | Not stated | Not stated | Not stated | — |
| WW (WeightWatchers) | Med+ membership: $25 first month, then $74/mo (12-month plan) or $84/mo (6-month plan); medication billed separatelyChecked 2 Oct 2026 | Wegovy, Saxenda, Zepbound, Foundayo | Not stated | — |
| Noom | $79 to start, then $179/mo (billed quarterly, medication included); higher GLP-1 tiers up to $299/mo; branded-medication plan $39 to start, then $129/mo, medication not includedChecked 2 Oct 2026 | GLP-1 programs (drug and compounding status not stated by tier), Branded GLP-1 (prescription only) | Not available in all 50 states (list not given on page) | — |
| Hims | Not stated | Not stated | Not stated | — |
| Fridays | Semaglutide from $117/mo, tirzepatide from $198/mo (promotional pricing as shown); brand Ozempic $1,498/mo, Zepbound $1,828/moChecked 2 Oct 2026 | Semaglutide (compounded and brand), Tirzepatide (compounded and brand) | Not stated | — |
| Eden | Not stated | Not stated | Not stated | — |
| Shed | Compounded semaglutide from $159/mo, compounded tirzepatide from $239/moChecked 2 Oct 2026 | Compounded semaglutide, Compounded tirzepatide, Wegovy, Zepbound, Sermorelin, NAD+ | All 50 states; treatment availability may vary by state | — |
| Found | Plans from $99/mo with insurance or $169/mo cash; medication included on compounded plansChecked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Wegovy, Zepbound, Ozempic, Mounjaro | Not available in all states (full list not given) | — |
| Mochi Health | Membership $79/mo plus medication (compounded tirzepatide "as low as" $90, compounded semaglutide "as low as" $60)Checked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Zepbound, Wegovy, Mounjaro, Ozempic | Availability and pricing vary by state (list not given) | — |
| Emerge | Not stated | Not stated | Not stated | — |
| Maximus | Compounded tirzepatide from $249.99/mo (2-month plan); brand-name GLP-1s from $199.99 (period not stated)Checked 2 Oct 2026 | Compounded tirzepatide, Wegovy, Zepbound, Ozempic, Mounjaro, Testosterone | Not stated | — |
| Midi Health | Not stated | GLP-1 prescriptions (drug not named on page), Hormone therapy | Available in all 50 states | — |
| AgelessRx | Microdosing tirzepatide from $159/mo, microdosing semaglutide from $99/mo, sermorelin from $99/moChecked 2 Oct 2026 | Microdosing tirzepatide, Microdosing semaglutide, Sermorelin, NAD+ injection | Not stated | — |
| Sesame | Wegovy pill from $149/month; visits from $34Checked 2 Oct 2026 | Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus | Not stated | — |
| TrimRx | Not stated | Not stated | Not stated | — |
| OrderlyMeds | Compounded tirzepatide from $149/mo then $299/mo; compounded semaglutide from $74/mo then $149/mo (starter dose, paid upfront)Checked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Zepbound, Wegovy | Licensed clinicians in all 50 states | — |
| LifeMD | Wegovy from $149 (billing period not stated)Checked 2 Oct 2026 | Wegovy, Compounded GLP-1 (where the provider prescribes) | Not stated | — |
| Henry Meds | Not stated | Not stated | Not stated | — |
| Remedy Meds | Not stated | Compounded GLP-1s | Not stated | — |
| Sprout Health | Not stated | Not stated | Not stated | — |
| Calibrate | $199/mo Metabolic Reset program (3-month minimum)Checked 2 Oct 2026 | Wegovy, Ozempic, Mounjaro, Zepbound | Not stated | — |
| SkinnyRx | From $99 for the first month (injectables); ongoing price not statedChecked 2 Oct 2026 | Tirzepatide injection, Semaglutide injection, Wegovy pill | Not stated | — |
| Measured | Membership from $49/mo; medication priced separatelyChecked 2 Oct 2026 | Wegovy, Wegovy pill, Zepbound, Compounded GLP-1 | Not stated | — |
| IVIM Health | Compounded tirzepatide $133/mo and compounded semaglutide $75/mo (6-month plans); membership $75/mo, first month freeChecked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Zepbound, Wegovy, Sermorelin (coming soon) | Not stated | — |
| Hone Health | Membership tiers $25 to $155/mo plus cost of medication (hormone and longevity care; no GLP-1 price stated)Checked 2 Oct 2026 | Not stated | Not stated | — |
| Push Health | Not stated | Not stated | Not stated | — |
| Juniper | Not stated | Not stated | Not stated | — |
What people search
- compounded tirzepatide40,500/mo
- compounded tirzepatide cost2,400/mo
- compounded tirzepatide dosage chart1,600/mo
US monthly searches, Google Keyword Planner, Oct 2026. Shown so you can see which questions this page answers.
Sources
- 1FDA warning letters to five research-peptide sellersFDA warning letter (NuScience Peptides; 1 of 5) · 2026fda.govAccessed 2 Oct 2026
- 2FDA proposes excluding semaglutide, tirzepatide and liraglutide from the 503B bulks listFDA · 2026fda.govAccessed 2 Oct 2026
- 3Seven FDA warning letters to online sellers of GLP-1 productsFDA warning letter (Gram Peptides; 1 of 7) · 2026fda.govAccessed 2 Oct 2026
Found an error? Report a correction.